Method of treating patients with a mucinous glycoprotein...

Details Method of treating patients with a mucinous glycoprotein... Method of treating patients with a mucinous glycoprotein...

A - Human Necessities

61

K

A61K 38/16 (2006.01) A61K 9/127 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2613327

The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-I -based formulation. The formulation may be a MUC-I based liposomal vaccine formulation.

La présente invention a trait à un procédé pour le traitement d'un sujet atteint d'un cancer, tel qu'un cancer du poumon "non à petites cellules" ou un cancer de la prostate, par l'administration d'une formulation à base de glycoprotéine mucineuse. La formulation peut être une formulation vaccinale liposomale à base de glycoprotéine mucineuse.

Affiliated with

Also associated with

Rating

Method of treating patients with a mucinous glycoprotein... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating patients with a mucinous glycoprotein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating patients with a mucinous glycoprotein... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2008619